NexPoint Real Estate Finance, Inc. (NREF) Market Cap
NexPoint Real Estate Finance, Inc. has a market capitalization of $248.5M.
Financials based on reported quarter end 2025-12-31
Price: $14.06
▲ 0.13 (0.93%)
Market Cap: 248.48M
NYSE · time unavailable
CEO: James David Dondero
Sector: Real Estate
Industry: REIT - Mortgage
IPO Date: 2020-02-07
Website: https://www.nexpointfinance.com
NexPoint Real Estate Finance, Inc. (NREF) - Company Information
Market Cap: 248.48M · Sector: Real Estate
NexPoint Real Estate Finance, Inc. operates as a real estate finance company in the United States. It focuses on originating, structuring, and investing in first mortgage loans, mezzanine loans, preferred equity, and preferred stock, as well as multifamily commercial mortgage backed securities securitizations. The company intends to qualify as a real estate investment trust for U.S. federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2019 and is based in Dallas, Texas.
Analyst Sentiment
Based on 4 ratings
Analyst 1Y Forecast: $15.00
Average target (based on 2 sources)
Consensus Price Target
Low
$15
Median
$15
High
$15
Average
$15
Potential Upside: 6.7%
Price & Moving Averages
Related Companies in Real Estate
AG MORTGAGE INVESTMENT TRUST REIT (MITT)
Real Estate
$0.25B
Mkt Cap
SERVICE PROPERTIES TRUST (SVC)
Real Estate
$0.24B
Mkt Cap
CHICAGO ATLANTIC REAL ESTATE FINAN (REFI)
Real Estate
$0.26B
Mkt Cap
STRATUS PROPERTIES INC (STRS)
Real Estate
$0.24B
Mkt Cap
AMERICAN REALTY INVESTORS INC (ARL)
Real Estate
$0.23B
Mkt Cap
ANGEL OAK MORTGAGE REIT INC (AOMR)
Real Estate
$0.23B
Mkt Cap
Management framed Q4 as solid execution (CAD dividend coverage at 1.06x; book value up 1.4%; Alewife leasing momentum and self-storage outperformance). However, analyst pressure centered on whether dividend sustainability and credit costs are under control. On dividend coverage, CFO emphasized that EAD is below CAD largely due to non-cash bridges (amortization/premium accretion/REO depreciation) and leaned on re-REMIC plus ongoing Series C capital deployment with an asserted 200–400 bps net interest margin expansion potential. On credit, the Q&A disclosed a sizable ~$12M CECL provision driven by a more conservative severe downside scenario—largely already-reserved pref exposure—though management’s key comfort is that the provision should level off in 2026. The other pressure point was policy risk: DC’s proposed limitations may hit scattered-site SFR financeability, but management sees ABS origination still 'wide open' and views the potential for institutional retreat as an opportunity.
Growth Catalysts
- Alewife Park life science leasing momentum: now 64% leased; RFPs/LOIs/leases total 2.8x the square footage; expected fully leased in 2026
- Self-storage portfolio outperformance: 91.7% occupancy in 2025 vs industry 89% (and NOI budget exceeded by 3.2%), NOI +13% vs 2024
- BTR/multifamily deployment via 'B-notes' and sale of A-notes for new construction and new lease-up
Business Development
- Re-REMIC transaction with Mizuho on 2017-K62 D/B piece: sell the B piece and purchase a horizontal risk retention tranche (~5.8% of the re-REMICs)
- Series C 8% preferred stock launch: sold ~80,000 shares for ~$2.0M gross proceeds through end of year and additional $14.1M total through today (as stated)
- BTR sandbox relationships/efforts to market direct BTR new construction: 'Walkers and Dunlops', JLL, and 'the CBs' (named generally)
Financial Highlights
- Q4 net income: $0.52 per diluted share vs $0.043 in Q4 2024 (driven by unrealized gains on preferred stock and stock warrant investments)
- Earnings available for distribution (EAD): $0.48 per diluted share vs $0.83 in Q4 2024
- Cash available for distribution (CAD): $0.53 per diluted share vs $0.47 prior quarter; dividend $0.50/share paid; dividend covered at 1.06x by CAD
- Book value per share: $19.10 (+1.4% QoQ) primarily from unrealized gains on preferred stock and stock warrants
- New loan funding in Q4: $5.7M at SOFR + 900 bps with 14% floor; $22.5M at 11%; $17.4M across two marina loans at 13%
- Capital markets: $60.5M gross proceeds raised from Series B preferred stock offering
- Q1 guidance: EAD $0.40/share midpoint (range $0.35-$0.45); CAD $0.50/share midpoint (range $0.45-$0.55)
- Q1 guidance: debt reduction of $75.2M; debt-to-equity target 0.83x; HRR tranche expected yield 18.5%
- Dividend 2026 declared: $0.50/share
- Credit loss provision/CECL: ~ $12M provision in the quarter (1/3 general reserve; 2/3 on deals already reserved under CECL, mainly certain pref deals from last quarter); expectation: level off in 2026
Capital Funding
- Refinancing/terming out: $180M of unsecured notes maturing in May 2026; company actively reviewing options for best execution/pricing
- Series C preferred: 8% preferred stock at $25/share; ~80,000 shares sold for ~$2M gross by year-end; $14.1M through today
- Subsequent to quarter-end: re-REMIC with Mizuho to reduce mark-to-market repo financing; expected interest expense savings and reinvestment capacity around $0.30-$0.34 per share accretive to annual CAD
- Q1 leverage/capital action: debt reduced by $75.2M; debt-to-equity down to 0.83x
Strategy & Ops
- Active management of B-piece portfolio via re-REMIC to improve capital efficiency (unlock value; reduce mark-to-market repo financing)
- Cost of capital focus to drive results (management emphasis on 'go on the offensive' and cost of capital)
- Portfolio positioning toward recession-resilient sectors (residential and self-storage) and first-to-fill life science
- Automation/tech not mentioned; no store closures mentioned; supply chain shifts not mentioned
Market Outlook
- Self-storage: Q4 and full-year expected flat revenue and 50-150 bps decline in NOI; occupancy pressured with industry ending 2025 at 89% (-210 bps YoY vs start of year); deliveries projected as low as 1% over next couple of years
- Self-storage outlook: NOI growth expected to moderate to ~4% in 2026 (portfolio stabilization, softer demand, rate constraints on two LA properties); return to historical 3%-5% NOI growth expected eventually
- Residential/multifamily: rent inflection expected in 2026; cited drivers include 60% decline in new market-rate deliveries from peak and construction starts ~70% below 2020 peak
- Life science: Alewife fully leased in 2026; expected to yield a debt yield with a '12-handle' (i.e., ~12%)
- BTR pipeline reviewed: $5.555B of BTR and $90M of multifamily product under review
- BTR 'sandbox' scale (single-family equity business): ~$550M of BTR under contract; ~ $200M of new build-to-rent construction product under review in any given month
Risks & Headwinds
- Self-storage headwind: sluggish housing market (home sales near multiyear lows) and elevated mortgage rates reducing a key demand driver
- Credit/CECL risk: provision of ~$12M reflects updated, more conservative CECL with a severe downside scenario; expectation it levels off in 2026
- Regulatory/political risk: proposed DC regulations limiting institutional ownership in build-to-rent/scattered-site SFR; management says too early to tell but acknowledges focus could be on limiting institutional buyers of scattered-site SFR (financeability/ABS market could be affected)
- Rate/macro pressure: self-storage demand constrained by rates; company notes rates trending up since May 2025 as partial offset to occupancy weakness
Sentiment: MIXED
Note: This summary was synthesized by AI from the NREF Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.
Fundamentals Overview
📊 AI Financial Analysis
Powered by StockMarketInfo"Revenue for NREF rose to $33.70M in 4Q25, up +3.7% QoQ (+10.8% vs 1Q25), indicating a modest top-line improvement. However, net income fell sharply to $21.39M in 4Q25 from $43.08M in 3Q25 (−50.4% QoQ), highlighting significant quarter-to-quarter earnings volatility. Net margin remains high but unstable: ~63% in 4Q25 versus ~133% in 3Q25. On profitability consistency, the absence of a directly comparable 4Q24 fundamentals period in the provided dataset prevents a reliable YoY revenue/net income calculation. From a balance-sheet perspective, total assets edged up (+0.9% QoQ) and equity improved (+7.6% QoQ), while net debt declined slightly (−0.6% QoQ), suggesting improving resilience. Cash flow data provided for prior quarters shows positive free cash flow, but dividends have been a meaningful cash outflow (dividends paid ~-$13M to -$16M per quarter). The current dividend yield is ~2.5% with a payout ratio of ~0.29 at 4Q25, which looks more covered than earlier quarters. Shareholder returns are modest: the stock is up ~5% over 1Y, and combining this with the ~2.5% yield implies total return is still mid-single digits. With a consensus price target of $15 vs $14.07, valuation upside appears limited but valuation multiples are low (P/E ~2.9)."
Revenue Growth
4Q25 revenue of $33.70M was +3.7% QoQ higher. YoY growth for 4Q25 vs 4Q24 cannot be computed from the provided fundamentals (4Q24 revenue/net income not included).
Profitability
Net income declined −50.4% QoQ (4Q25: $21.39M vs 3Q25: $43.08M), showing earnings volatility. Net margin remains high (~63%) but contracted materially vs ~133% in 3Q25.
Cash Flow Quality
FCF is not provided for the latest quarter, limiting confirmation of coverage at 4Q25. In earlier quarters, free cash flow was positive, but dividends consumed a substantial portion of cash outflows; latest payout ratio (~0.29) suggests better coverage than earlier quarters.
Leverage & Balance Sheet
Total assets increased +0.9% QoQ and equity rose +7.6% QoQ. Net debt decreased slightly (−0.6% QoQ), indicating modest balance-sheet improvement.
Shareholder Returns
1Y price performance is +5.0%. With a current dividend yield of ~2.5%, total shareholder return is estimated to be in the high-single digits. No buyback information provided.
Analyst Sentiment & Valuation
Consensus target is $15 vs $14.07 (about ~6.6% upside). Valuation appears inexpensive (P/E ~2.9 at 4Q25), supporting a steadier downside profile, though earnings volatility remains a risk.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.